Trial shows drug effective in 96% of patients with recurrent pericarditis
Cleveland Clinic researchers leading a global clinical trial have found that rilonacept, an FDA approved drug for other inflammatory diseases, resolved acute pericarditis episodes and reduced risk of pericarditis recurrence. ...
Nov 17, 2020
0
2